Discovery and Biological Characterization of 1-[4-(2-Difluoromethoxyphenyl)-5-methylthiazol-2-yl]-3-(naphthalen-1-yl)urea (DFMNTU): A Novel Thiazolyl-Urea Chemotype Targeting Yellow Fever Virus and Host Casein Kinase 2 (CK2)
Anatolii Demchenko, Artur Martynov, Galyna Volynets, Volodymyr Bdzhola, Mykhailo Mahdysiuk, Sergii Demchenko, Sergii Yarmoluk, Dmytro Zaporozhets, Volodymyr Sukhovieiev, Mariia Usenko, Oksana Gorbatiuk, Svitlana V Antonenko, Volodymyr Zaitsev
European Journal of Pharmaceutical Sciences. 2026 Oct 3:107679. Online ahead of print. PMID: 42829118
https://doi.org/10.1016/j.ejps.2026.107679 ↗
Synthesis and structure-activity relationship of 4,6-bis(pyrrolidin-1-yl)-1,3,5-triazines, their antiviral activity against yellow fever and Tacaribe viruses
Anatolii Demchenko, Artur Martynov, Yevhenii Novodvorskyi, Andrii Tsyhankov, Albina Mikhraliieva, Oleh Moskalenko, Oleh Yadlovskyi, Sergii Demchenko, Sergii Tsyhankov, Sergii Yarmoluk, Volodymyr Zaitsev
Results in Chemistry, August 2026, Volume 28, 103613
https://doi.org/10.1016/j.rechem.2026.103613 ↗
Design, synthesis, and in vitro anticancer and anti-influenza evaluation of 2-amino-3-benzoyl-N-indolizine-1-carboxamide derivatives
Anatolii Demchenko, Ivan Iurchenko, Volodymyr Zaitsev, Yevhenii Novodvorskyi, Volodymyr Sukhovieiev, Lida Zavodovska, Sergii Demchenko, Sergii Tarnavsky & Sergii Yarmoluk
Chemical Papers (2026)
https://doi.org/10.1007/s11696-026-05188-4 ↗
Neurotropic Effects In Vivo of New Tryptamino-Triazines Compared to GABA Effectors
Anatoly Demchenko; Artur Martynov; Yevhenii Novodvorskyi; Oleh Yadlovskyi; Oleh Moskalenko; Tatyana Bomko; Tatyana Nosalsky; Sergii Demchenko; Sergiy Yarmoluk
ACS Chemical Neuroscience, 2025, 16 (24), 4769–4782
https://doi.org/10.1021/acschemneuro.5c00884 ↗
Discovery of new aurone derivatives as submicromolar CK2 inhibitors
Mahdysiuk MV, Volynets GP, Bdzhola VG, Bieda OA, Lukashov SS, Sapelkin VM, Karbovskyi LL, Yarmoluk SM
J Enzyme Inhib Med Chem. 2025 Dec; 40(1):2566780. Epub 2025 Oct 9. PMID: 41065365
https://doi.org/10.1080/14756366.2025.2566780 ↗
Identification of novel Mycobacterium tuberculosis leucyl-tRNA synthetase inhibitors with antibacterial activity
Volynets GP, Gudzera OI, Lukashov SS, Gorbatiuk OB, Usenko MO, Ruban TP, Protopopov MV, Tarnavskiy SS, Kotey IM, Bdzhola VG, Prykhod'ko AO, Lukash LL, Yarmoluk SM, Tukalo MA
Future Med Chem. 2025 Apr; 17(7):757–765. Epub 2025 Apr 21. PMID: 40259683
https://doi.org/10.1080/17568919.2025.2485673 ↗
Probing the Molecular Basis of Aminoacyl-Adenylate Affinity With Mycobacterium tuberculosis Leucyl-tRNA Synthetase Employing Molecular Dynamics, Umbrella Sampling Simulations and Site-Directed Mutagenesis
Volynets GP, Gudzera OI, Usenko MO, Gorbatiuk OB, Bdzhola VG, Kotey IM, Balanda AO, Prykhod'ko AO, Lukashov SS, Chuk OA, Skydanovych OI, Yaremchuk GD, Yarmoluk SM, Tukalo MA
J Mol Recognit. 2025 Mar; 38(2):e3110. Epub 2024 Oct 31. PMID: 39478352
https://doi.org/10.1002/jmr.3110 ↗
Syntheses and evaluation of novel 3-hydroxy-1,3-diaryl-2,3,5,6,7,8-hexahydro-imidazo[1,2-a]pyridine-1-ium bromides as potential anticancer agents
Sergii Demchenko, Sergii Yarmoluk, Volodymyr Sukhovieiev, Oleksandr Golovchenko, Oleksandr Sukhovieiev, Anatolii Demchenko
Pharmacia, 2024, 71, 1–10
https://doi.org/10.3897/pharmacia.71.e135992 ↗
Fused Triazole-Azepine Hybrids as Potential Non-Steroidal Antiinflammatory Agents
Sergii Demchenko, Roman Lesyk, Oleh Yadlovskyi, Serhii Holota, Sergii Yarmoluk, Sergii Tsyhankov, Anatolii Demchenko
Scientia Pharmaceutica, 2023, 91(2), 26
https://doi.org/10.3390/scipharm91020026 ↗